These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28151013)

  • 1. Sex-Determining Region Y-box 2 Promotes Growth of Lung Squamous Cell Carcinoma and Directly Targets Cyclin D1.
    Li C; He B; Huang C; Yang H; Cao L; Huang J; Hu C
    DNA Cell Biol; 2017 Apr; 36(4):264-272. PubMed ID: 28151013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
    Fukazawa T; Guo M; Ishida N; Yamatsuji T; Takaoka M; Yokota E; Haisa M; Miyake N; Ikeda T; Okui T; Takigawa N; Maeda Y; Naomoto Y
    Sci Rep; 2016 Feb; 6():20113. PubMed ID: 26846300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.
    Fang WT; Fan CC; Li SM; Jang TH; Lin HP; Shih NY; Chen CH; Wang TY; Huang SF; Lee AY; Liu YL; Tsai FY; Huang CT; Yang SJ; Yen LJ; Chuu CP; Chen CY; Hsiung CA; Chang JY; Wang LH; Chang IS; Jiang SS
    Int J Cancer; 2014 Aug; 135(4):809-19. PubMed ID: 24477565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers.
    Harada M; Kotake Y; Ohhata T; Kitagawa K; Niida H; Matsuura S; Funai K; Sugimura H; Suda T; Kitagawa M
    Genes Cells; 2014 Jun; 19(6):504-16. PubMed ID: 24774443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
    Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
    Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
    Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
    Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
    Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
    PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.
    Hussenet T; du Manoir S
    Cell Cycle; 2010 Apr; 9(8):1480-6. PubMed ID: 20372069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.
    Hur JY; Kim HR; Lee JY; Park S; Hwang JA; Kim WS; Yoon S; Choi CM; Rho JK; Lee JC
    Cell Oncol (Dordr); 2019 Aug; 42(4):449-458. PubMed ID: 30838525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.
    Chuang WY; Chang YS; Chao YK; Yeh CJ; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
    Int J Clin Exp Pathol; 2015; 8(8):9248-55. PubMed ID: 26464673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of MYCN promotes proliferation of non-small cell lung cancer.
    Liu K; Wang S; Liu Y; Gu J; Gu S; Xu Z; Zhang R; Wang Z; Ma H; Chen Y; Ji L
    Tumour Biol; 2016 Sep; 37(9):12855-12866. PubMed ID: 27449038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
    Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
    Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
    Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.
    Brcic L; Sherer CK; Shuai Y; Hornick JL; Chirieac LR; Dacic S
    Am J Clin Pathol; 2012 Nov; 138(5):712-8. PubMed ID: 23086772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity.
    Wu F; Zhang J; Wang P; Ye X; Jung K; Bone KM; Pearson JD; Ingham RJ; McMullen TP; Ma Y; Lai R
    Cell Signal; 2012 Nov; 24(11):1989-98. PubMed ID: 22800865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.
    Hussenet T; Dali S; Exinger J; Monga B; Jost B; Dembelé D; Martinet N; Thibault C; Huelsken J; Brambilla E; du Manoir S
    PLoS One; 2010 Jan; 5(1):e8960. PubMed ID: 20126410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
    Yang N; Wang Y; Hui L; Li X; Jiang X
    J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More expression of BDNF associates with lung squamous cell carcinoma and is critical to the proliferation and invasion of lung cancer cells.
    Zhang SY; Hui LP; Li CY; Gao J; Cui ZS; Qiu XS
    BMC Cancer; 2016 Feb; 16():171. PubMed ID: 26926340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miR-145 in human laryngeal squamous cell carcinoma.
    Karatas OF; Yuceturk B; Suer I; Yilmaz M; Cansiz H; Solak M; Ittmann M; Ozen M
    Head Neck; 2016 Feb; 38(2):260-6. PubMed ID: 26083661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF4 suppresses the tumor activity of cutaneous squamous cell carcinoma (SCC) cells via the regulation of SMAD signaling and SOX2 expression.
    Li XM; Kim SJ; Hong DK; Jung KE; Choi CW; Seo YJ; Lee JH; Lee Y; Kim CD
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1110-1115. PubMed ID: 31284949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.